Novartis AG
PHARMACEUTICAL CARRIER DESIGN
Last updated:
Abstract:
A pharmaceutical carrier (20) comprises a lid part (22) and a bottom part (24), wherein at least one of the lid part (22) and the bottom part (24) has a first wall section (26, 30) with a thickness of 180-250 .mu.m, preferably 185-225 .mu.m, even more preferably 190-220 .mu.m, and most preferably about 215 .mu.m, and a second wall section (28, 32) with a thickness of 350-450 .mu.m, preferably 375-425 .mu.m, more preferably 390-410 .mu.m, and most preferably about 400 .mu.m. The first wall section (26) of the lid part (22) defines an entire top portion of the lid part (22). Alternatively or additionally thereto, the first wall section (30) of the bottom part (24) defines an entire bottom portion of the bottom part (24).
Utility
28 Sep 2018
6 Aug 2020